Explore how genetic testing and precision oncology are revolutionizing cancer treatment by offering personalized care and ...

Chennai: At least two gene mutations are more common in Indian women who develop breast cancer, the Bharat Cancer Genome ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell ca ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

and also in cancer development. Besides describing the basic mechanisms governing programmed cell death, a large part of this review is dedicated to previous studies that were focused on screening ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

The following is a summary of “Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s,” published in the January 2025 issue of Pulmonology by Mosleh et al. Sex-based ...

Although Nor Haryati has finished her treatment, doctors were loathe to say she was cancer-free due to the genetic mutation.

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...